Paper40116625
Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.
Hassanein A and 1 other. Biomol Biomed, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. Papers, record 40116625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40116625
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Stem Cell Transplantation | Major topic |
| Stem Cells | Major topic |
| Humans | |
| Insulin-Secreting Cells | |
| Animals |
Source PubMed
References128
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31180194 | An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31180194 | PubMed |
| 2 | 27525644 | Effects of Composition of Alginate-Polyethylene Glycol Microcapsules and Transplant Site on Encapsulated Islet Graft Outcomes in Mice. | Transplantation | 2017 | https://conductscience.org/library/papers/27525644 | PubMed |
| 3 | 21205883 | Genetics of type 1 diabetes. | Clin Chem | 2011 | https://conductscience.org/library/papers/21205883 | PubMed |
| 4 | 31850335 | Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook. | Front Bioeng Biotechnol | 2019 | https://conductscience.org/library/papers/31850335 | PubMed |
| 5 | 35255603 | Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors. | Endocrinol Metab (Seoul) | 2022 | https://conductscience.org/library/papers/35255603 | PubMed |
| 6 | 38360355 | Encapsulation and immune protection for type 1 diabetes cell therapy. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38360355 | PubMed |
| 7 | 33990318 | An inverse-breathing encapsulation system for cell delivery. | Sci Adv | 2021 | https://conductscience.org/library/papers/33990318 | PubMed |
| 8 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 9 | 34959358 | Assessing the Effects of VEGF Releasing Microspheres on the Angiogenic and Foreign Body Response to a 3D Printed Silicone-Based Macroencapsulation Device. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34959358 | PubMed |
| 10 | 19583810 | The immune boundaries for stem cell based therapies: problems and prospective solutions. | J Cell Mol Med | 2009 | https://conductscience.org/library/papers/19583810 | PubMed |
| 11 | 39595139 | Alginate-Poly[2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595139 | PubMed |
| 12 | 33083260 | Current Perspective on Auto-antibodies in Type 1 Diabetes. | Indian J Endocrinol Metab | 2020 | https://conductscience.org/library/papers/33083260 | PubMed |
| 13 | 36731781 | Localized cytotoxic T cell-associated antigen 4 and antioxidant islet encapsulation alters macrophage signaling and induces regulatory and anergic T cells to enhance allograft survival. | Am J Transplant | 2023 | https://conductscience.org/library/papers/36731781 | PubMed |
| 14 | 37156915 | Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. | Nat Biotechnol | 2024 | https://conductscience.org/library/papers/37156915 | PubMed |
| 15 | 37043559 | Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37043559 | PubMed |
| 16 | 32080339 | Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32080339 | PubMed |
| 17 | 18991254 | Optimal implantation site for pancreatic islet transplantation. | Br J Surg | 2008 | https://conductscience.org/library/papers/18991254 | PubMed |
| 18 | 22233865 | Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells. | BMC Med | 2012 | https://conductscience.org/library/papers/22233865 | PubMed |
| 19 | 37712342 | Short-term function and immune-protection of microencapsulated adult porcine islets with alginate incorporating CXCL12 in healthy and diabetic non-human primates without systemic immune suppression: A pilot study. | Xenotransplantation | 2023 | https://conductscience.org/library/papers/37712342 | PubMed |
| 20 | 16904174 | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. | Cell | 2006 | https://conductscience.org/library/papers/16904174 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972590 | Emerging molecular and cellular therapeutics for type 2 diabetes: integrating stem cell and miRNA approaches toward precision medicine. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42972590 | PubMed |
| 42897562 | The role of the epidermal growth factor receptor (EGFR/ErbB1) in diabetic retinopathy and its therapeutic implications. | J Transl Med | 2026 | https://conductscience.org/library/papers/42897562 | PubMed |
| 42756827 | Precision Genome Engineering in Human Disease: Expanding Therapeutic Roles of CRISPR Technologies. | Niger Med J | 2026 | https://conductscience.org/library/papers/42756827 | PubMed |
| 42542743 | Cell-Based Therapies for Type 1 Diabetes: A Narrative Review of Stem Cell-Derived Islets, Encapsulation Strategies, and Recent Clinical Trials. | Cureus | 2026 | https://conductscience.org/library/papers/42542743 | PubMed |
| 42353029 | Metagenomic Insights into Gut Microbiota Alterations Following Dendrobium huoshanense Water Extract Intervention in Streptozotocin-Induced Type 1 Diabetic Rats. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353029 | PubMed |
| 42104727 | Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection. | Animal Model Exp Med | 2026 | https://conductscience.org/library/papers/42104727 | PubMed |
| 41379378 | Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells. | Tissue Eng Regen Med | 2026 | https://conductscience.org/library/papers/41379378 | PubMed |
| 40428118 | Assessing Implantation Sites for Pancreatic Islet Cell Transplantation: Implications for Type 1 Diabetes Mellitus Treatment. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40428118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40116625
GET https://conductscience.org/api/papers/v1/40116625/references?page=2